Health news, medical discoveries and wellness tips
A new UF Health study suggests glucosamine, a common joint supplement, may accelerate the progression of mild cognitive impairment to dementia. Analysis of health records showed a 25% higher likelihood of progression, and lab experiments indicate it might interfere with brain metabolism.
Stanford professor Bryant Lin, a lung cancer patient, shares his experience with cutting-edge targeted therapies. Despite personal challenges and high costs, he highlights significant progress and future potential in making lung cancer a chronic, manageable disease.
In Lesotho, young shepherds descend treacherous mountain paths nightly to attend basic literacy classes, seeking a better future despite poverty and tradition forcing them into herding. These volunteer-run schools offer a vital second chance.
A study reveals that common scented cleaning products react with indoor ozone to create billions of nanoparticles. These ultrafine particles can penetrate deep into the lungs, posing a significant health risk comparable to heavy traffic pollution.
New research suggests tirzepatide (Mounjaro/Zepbound) may combat obesity by activating calorie-burning brown fat in mice, offering a metabolic benefit beyond appetite control. If proven in humans, this could enhance obesity and diabetes treatments.
Star Meat Delivery Inc. has recalled 167,639 pounds of raw goat, beef, and pork. The meat was distributed under the A&D Foods label but lacked proper federal inspection, despite bearing a USDA mark of inspection with an unapproved plant number (EST. 1363).
A large UK Biobank study found that loneliness and social isolation can significantly reduce disease-free life expectancy, particularly for men's mental health. Healthy habits mitigated some, but not all, of the risks.
A three-decade US study shows stroke rates in adults aged 20-54 have nearly doubled. Ischemic strokes are the main driver, with rising risk factors like high blood pressure, diabetes, and substance use observed. More survivors face long-term disability.
A new study from WashU Medicine identified 34 blood proteins that change in patients receiving lecanemab, an anti-amyloid therapy for Alzheimer's. These shifts may offer a way to monitor treatment effectiveness and brain changes, potentially replacing expensive brain scans.